The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis

被引:64
作者
Alhomrani, Majid [1 ,2 ,3 ]
Correia, Jeanne [1 ,4 ]
Zavou, Marcus [1 ,2 ]
Leaw, Bryan [2 ,5 ]
Kuk, Nathan [1 ,4 ]
Xu, Rong [6 ]
Saad, Mohamed I. [2 ,7 ]
Hodge, Alexander [1 ,4 ]
Greening, David W. [6 ]
Lim, Rebecca [2 ,5 ]
Sievert, William [1 ,4 ]
机构
[1] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic, Australia
[2] Hudson Inst Med Res, Clayton, Vic, Australia
[3] Taif Univ, Med Coll, At Taif, Saudi Arabia
[4] Monash Hlth, Gastroenterol & Hepatol Unit, Clayton, Vic, Australia
[5] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia
[6] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, Melbourne, Vic, Australia
[7] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia
来源
FRONTIERS IN PHARMACOLOGY | 2017年 / 8卷
基金
英国医学研究理事会;
关键词
human amnion epithelial cells; extracellular vesicles; liver fibrosis; macrophages; anti-fibrotic therapy; secretome; soluble-factors; MESENCHYMAL STEM-CELLS; EXTRACELLULAR VESICLES; MACROPHAGE ACTIVATION; CONDITIONED MEDIUM; STELLATE CELLS; EMERGING ROLE; EXOSOMES; CANCER; TRANSPLANTATION; IMMUNOTHERAPY;
D O I
10.3389/fphar.2017.00748
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Hepatic stellate cells (HSCs) are the primary collagen-secreting cells in the liver. While HSCs are the major cell type involved in the pathogenesis of liver fibrosis, hepatic macrophages also play an important role in mediating fibrogenesis and fibrosis resolution. Previously, we observed a reduction in HSC activation, proliferation, and collagen synthesis following exposure to human amnion epithelial cells (hAEC) and hAEC-conditioned media (hAEC-CM). This suggested that specific factors secreted by hAEC might be effective in ameliorating liver fibrosis. hAEC-derived extracellular vesicles (hAEC-EVs), which are nanosized (40-100 nm) membrane bound vesicles, may act as novel cell-cell communicators. Accordingly, we evaluated the efficacy of hAEC-EV in modulating liver fibrosis in a mouse model of chronic liver fibrosis and in human HSC. Methods: The hAEC-EVs were isolated and characterized. C57BL/6 mice with CCl4-induced liver fibrosis were administered hAEC-EV, hAEC-CM, or hAEC-EV depleted medium (hAEC-EVDM). LX2 cells, a human HSC line, and bone marrow-derived mouse macrophages were exposed to hAEC-EV, hAEC-CM, and hAEC-EVDM. Mass spectrometry was used to examine the proteome profile of each preparation. Results: The extent of liver fibrosis and number of activated HSCs were reduced significantly in CCl4-treated mice given hAEC-EVs, hAEC-CM, and hAEC EVDM compared to untreated controls. Hepatic macrophages were significantly decreased in all treatment groups, where a predominant M2 phenotype was observed. Human HSCs cultured with hAEC-EV and hAEC-CM displayed a significant reduction in collagen synthesis and hAEC-EV, hAEC-CM, and hAEC-EVDM altered macrophage polarization in bone marrow-derived mouse macrophages. Proteome analysis showed that 164 proteins were unique to hAEC-EV in comparison to hAEC-CM and hAEC-EVDM, and 51 proteins were co-identified components with the hAEC-EV fraction. Conclusion: This study provides novel data showing that hAEC-derived EVs significantly reduced liver fibrosis and macrophage infiltration to an extent similar to hAEC-EVDM and hAEC-CM. hAEC-EV-based therapy may be a potential therapeutic option for liver fibrosis.
引用
收藏
页数:13
相关论文
共 74 条
  • [1] Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study
    Amin, Mona A.
    Sabry, Dina
    Rashed, Laila A.
    Aref, Wael M.
    el-Ghobary, Mohamed Ahmed
    Farhan, Marwa Salah
    Fouad, Hany Ahmed
    Youssef, Youssef Abdel-Aziz
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (04) : 607 - 612
  • [2] Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice
    An, Su Yeon
    Jang, Yu Jin
    Lim, Hee-Joung
    Han, Jiyou
    Lee, Jaehun
    Lee, Gyunggyu
    Park, Ji Young
    Park, Seo-Young
    Kim, Ji Hyang
    Do, Byung-Rok
    Han, Choongseong
    Park, Hee-Kyung
    Kim, Ok-Hee
    Song, Myeong Jun
    Kim, Say-June
    Kim, Jong-Hoon
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : 1174 - 1186
  • [3] Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages
    Atabai, Kamran
    Jame, Sina
    Azhar, Nabil
    Kuo, Alex
    Lam, Michael
    McKleroy, William
    DeHart, Greg
    Rahman, Salman
    Xia, Dee Dee
    Melton, Andrew C.
    Wolters, Paul
    Emson, Claire L.
    Turner, Scott M.
    Werb, Zena
    Sheppard, Dean
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (12) : 3713 - 3722
  • [4] Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion
    Atay, Safinur
    Banskota, Samagya
    Crow, Jennifer
    Sethi, Geetika
    Rink, Lori
    Godwin, Andrew K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (02) : 711 - 716
  • [5] Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy
    Baglio, Serena Rubina
    Pegtel, D. Michiel
    Baldini, Nicola
    [J]. FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [6] BANSAL R, 2015, SCI REP UK, V5
  • [7] Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation
    Bility, Moses T.
    Nio, Kouki
    Li, Feng
    McGivern, David R.
    Lemon, Stanley M.
    Feeney, Eoin R.
    Chung, Raymond T.
    Su, Lishan
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] Rap1 signalling: Adhering to new models
    Bos, JL
    de Rooij, J
    Reedquist, KA
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (05) : 369 - 377
  • [9] Emerging role of extracellular vesicles in inflammatory diseases
    Buzas, Edit I.
    Gyoergy, Bence
    Nagy, Gyoergy
    Falus, Andras
    Gay, Steffen
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (06) : 356 - 364
  • [10] Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
    Chang, F
    Lee, JT
    Navolanic, PM
    Steelman, LS
    Shelton, JG
    Blalock, WL
    Franklin, RA
    McCubrey, JA
    [J]. LEUKEMIA, 2003, 17 (03) : 590 - 603